Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Gynecol Oncol. 2014 Jan 14;132(3):722–729. doi: 10.1016/j.ygyno.2014.01.009

Figure 5.

Figure 5

Tumor response curves post intravenous administration of VVNIS-C or VVNIS-W in mice with subcutaneous (A–D) AN3 CA or (E–H) ARK-2 xenografts. Mice were randomly assigned to a single IV injection of saline, VVNIS-C or VVNIS-W (106 TCID50). A–C and E–G, Individual tumor volumes in each mouse. D and H, Average tumor volumes of each study group.